Calcium Phosphate, Tribasic

Summary

Calcium Phosphate, Tribasic (CHEMBL2106566) is a phase-3 clinical-stage small molecule; indicated across 1 condition including dental caries.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Small molecule
• Indications: 1 condition
• Clinical trials: 4
• Chemistry: 310.18 Da · Ca3O8P2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2106566
Name	Calcium Phosphate, Tribasic
Type	Small molecule
Max phase	3
FDA approved	no
PubChem CID	24456
ChEBI	CHEBI:9679
Molecular formula	Ca3O8P2
Molecular weight	310.18
InChIKey	QORWJWZARLRLPR-UHFFFAOYSA-H

SMILES: [O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2]

IUPAC name: tricalcium diphosphate

Also known as: Bone ash, Bone powder, purified, Calcium phosphate, tribasic, Durapatite, E-341(III), FEMA NO. 3081, INS NO.341(III), INS-341(III), Tribasic calcium phosphate, WIN 40350

Patent coverage: 220,405 distinct patent families (666,662 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

1 indication (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
dental caries	2	MONDO:0005276	EFO:0003819

Clinical trials

Total trials: 4.

Phase distribution

Phase	Trials
Not specified	3
PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00074711	PHASE2	COMPLETED	Adding Phosphorus to Osteoporosis Drug Treatment
NCT01296997	Not specified	COMPLETED	Calcium Phosphate and Incretins
NCT01297023	Not specified	COMPLETED	Human Intervention Study With Calcium Phosphate and Vitamin D
NCT03286673	Not specified	COMPLETED	Comparison of Three Calcium Supplements

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).